Sygnature Discovery Limited


Sygnature Discovery are a leading drug discovery CRO with expertise across a range of therapeutic and biological target classes. An expert partner in disciplines including Medicinal and Computational Chemistry, In Vitro and In Vivo Pharmacology, DMPK, supported by informatics.

Industries

Employees

201-500

Links


Org chart

Simon Hirst
Founder, CEO & Director
Collapse
Jonathan Williams
COO & Director
Louisa Jordison
CFO & Director
David Witty
Chief Scientific Officer
Allan Jordan
VP, Oncology Drug Discovery
John Unitt
VP, Immunology & Inflammation Drug Discovery
Max Mirza
VP, Neuroscience Drug Discovery
Emily Eaton
VP, Commercial Services
Geraint Jones
Director of Chemistry
Alex Stevens
Director DMPK
Aparna Chandrasekaran
Senior Scientist
Katarzyna Kopycka
Senior Scientist 2
Mark Thomas
Senior Vice President Human Resources


Offices

This company has no offices yet